The Effect of Antidepressant Treatment on Neurocognitive Functions, Redox and Inflammatory Parameters in the Context of COVID-19 DOI Open Access

Eliza Samaryn,

Beata Galińska-Skok, Aleksander Nobis

et al.

Journal of Clinical Medicine, Journal Year: 2023, Volume and Issue: 12(22), P. 7049 - 7049

Published: Nov. 12, 2023

Inflammation is an important component of the etiopathology depression that uses oxidative and nitrosative stress (O&NS) elevated inflammatory markers. SARS-CoV-2 infection also associated with abnormal processes, which may impair effective treatment in COVID-19 survivors. In presented study, thirty-three hospitalized patients major depressive disorder (MDD) were started on antidepressant treatment, twenty-one re-evaluated after 4–6 weeks. The control group consisted thirty healthy volunteers. All participants underwent neuropsychiatric evaluation, biochemical blood urine analyses. results research demonstrated positive correlations Hamilton Depression Rating Scale (HAM-D) scores serum catalase (CAT) urinary S-Nitrosothiols levels, Beck Inventory (BDI) reduced glutathione (GSH) superoxide dismutase (SOD) levels. Depressed a history prior to had higher nitric oxide (NO) levels lower peroxidase (GPx) group, survivors N-formylkynurenine (NFK). Our suggest has modulating effect O&NS, reduces symptoms improves cognitive functions present study does not indicate clinical response baseline antibody Nevertheless, further this area needed systematize

Language: Английский

Preliminary evaluation of the antiglycoxidant activity of verapamil using various in vitro and in silico biochemical/biophysical methods DOI Creative Commons
Miłosz Nesterowicz, Kamil Klaudiusz Lauko,

Karolina Dańkowska

et al.

Frontiers in Pharmacology, Journal Year: 2023, Volume and Issue: 14

Published: Nov. 28, 2023

Introduction: Glycoxidative stress is essential for linking glucose disturbances and cardiovascular diseases. Unfortunately, contemporary antidiabetic drugs do not have an antiglycative effect but only lower blood levels. Therefore, there intense search substances that could inhibit protein glycation prevent diabetic complications. A potential antioxidant activity has been demonstrated with verapamil, a phenylalkylamine derivative belonging to selective calcium channel blockers. Verapamil well-established position in cardiology due its wide range of indications good safety profile. Nevertheless, the verapamil still unclear. We are first comprehensively evaluate verapamil’s on glycoxidation using various vitro silico models. Methods: Bovine serum albumin (BSA) was used assess rate inhibition by verapamil. As glycating factors, sugars (glucose, fructose, ribose) aldehyde (glyoxal) were used. Chloramine T as oxidizing agent. Aminoguanidine (protein inhibitor) Trolox (antioxidant) control substances. The biomarkers oxidation (total thiols, carbonyls, advanced products), (Amadori products, β-amyloid, end products [AGEs]), (tryptophan, kynurenine, N-formylkynurenine, dityrosine) evaluated colorimetric fluorimetric methods. mechanism assessed docking study interaction BSA, glycosidases, seventeen AGE pathway proteins. Results: In all models, glycation, oxidation, significantly ameliorated under influence comparable potent antiglycating agents antioxidants. molecular simulations showed bound preferentially amino acids prone glycoxidative damage out α-glucosidase’s active center. Among proteins, best docked Janus kinase 2 (JAK2) nuclear factor-κB (NF-κB). Discussion: results our confirm antiglycoxidant properties drug’s action recognized protecting against oxidative modifications. may be particularly helpful patients disease concomitant diabetes. Studies animal models humans needed antiglycative/antidiabetic activity.

Language: Английский

Citations

4

Molecular docking, derivatization, characterization and biological assays of amantadine DOI
Zarmeena Yasmeen, Mohsin Abbas Khan, Irshad Ahmad

et al.

Future Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 16(18), P. 1853 - 1863

Published: Aug. 9, 2024

Derivatization has been tremendously utilized in the field of drug discovery for optimizing pharmacological properties and improving safety, efficacy selectivity.

Language: Английский

Citations

0

The Effect of Antidepressant Treatment on Neurocognitive Functions, Redox and Inflammatory Parameters in the Context of COVID-19 DOI Open Access

Eliza Samaryn,

Beata Galińska-Skok, Aleksander Nobis

et al.

Journal of Clinical Medicine, Journal Year: 2023, Volume and Issue: 12(22), P. 7049 - 7049

Published: Nov. 12, 2023

Inflammation is an important component of the etiopathology depression that uses oxidative and nitrosative stress (O&NS) elevated inflammatory markers. SARS-CoV-2 infection also associated with abnormal processes, which may impair effective treatment in COVID-19 survivors. In presented study, thirty-three hospitalized patients major depressive disorder (MDD) were started on antidepressant treatment, twenty-one re-evaluated after 4–6 weeks. The control group consisted thirty healthy volunteers. All participants underwent neuropsychiatric evaluation, biochemical blood urine analyses. results research demonstrated positive correlations Hamilton Depression Rating Scale (HAM-D) scores serum catalase (CAT) urinary S-Nitrosothiols levels, Beck Inventory (BDI) reduced glutathione (GSH) superoxide dismutase (SOD) levels. Depressed a history prior to had higher nitric oxide (NO) levels lower peroxidase (GPx) group, survivors N-formylkynurenine (NFK). Our suggest has modulating effect O&NS, reduces symptoms improves cognitive functions present study does not indicate clinical response baseline antibody Nevertheless, further this area needed systematize

Language: Английский

Citations

1